Active — Not RecruitingNot Applicable

The Study on the Safety and Efficacy of the G-iliac Iliac Bifurcation Stent Graft System

China500 participantsStarted 2021-11-30

Plain-language summary

The objective of this study is to evaluate the Safety and Efficacy of the G-iliac Iliac Bifurcation Stent Graft System for Endovascular Repair of Common Iliac Artery Aneurysms(CIAA).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who have undergone implantation of the iliac bifurcation stent graft system; * Patients with complete medical records Exclusion Criteria: * Patients with ruptured aortic aneurysm; * Patients with infected or mycotic aortic aneurysm; * Patients with connective tissue diseases, such as systemic lupus erythematosus, Marfan syndrome, Ehlers-Danlos syndrome, or Behcet's disease

What they're measuring

The Incidence of Major Adverse Events (MAE) within 30 Days postoperatively.

Timeframe: within 30 Days postoperatively

he patency rate of internal iliac artery (IIA) at 12 months postoperatively

Timeframe: at 12 months postoperatively

Trial details

NCT IDNCT06660927

SponsorLifetech Scientific (Shenzhen) Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-11-30

View on ClinicalTrials.gov More Common Iliac Artery Aneurysm trials